MLN1202
MLN1202/CPH-001
Phase 1 small_molecule terminated
Quick answer
MLN1202 for Healthy Japanese and Caucasian Male Adults is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Healthy Japanese and Caucasian Male Adults
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated